Stockholders' Equity

3 Months Ended

Mar. 31, 2020

Stockholders' Equity

Stockholders' Equity

9. Stockholders’ Equity

Common Stock Dividends

	For the three months ended
	March 31,
	2020		2019
Dividends declared per common share	$	0.56	$	0.54

Reconciliation of Outstanding Common Shares

	For the three months ended
	March 31,
	2020	2019
	(in millions)
Beginning balance	276.6	279.5
Shares issued	1.2	1.8
Treasury stock acquired	(4.4)	(3.1)
Ending balance	273.4	278.2

In November 2018, our Board of Directors authorized a share repurchase program of up to $500.0 million of our outstanding common stock, which was completed in February 2020. In February 2020, our Board of Directors authorized a share repurchase program of up to $900.0 million of our outstanding common stock, which has no expiration date.

Other Comprehensive Income (Loss)

	For the three months ended
	March 31, 2020
	Pre-Tax		Tax		After-Tax
	(in millions)
Net unrealized losses on available-for-sale securities during the period	$	(2,777.7)	$	600.3	$	(2,177.4)
Reclassification adjustment for gains included in net income (1)		(9.5)		2.6		(6.9)
Adjustments for assumed changes in amortization patterns		332.5		(69.8)		262.7
Adjustments for assumed changes in policyholder liabilities		662.2		(152.2)		510.0
Net unrealized losses on available-for-sale securities		(1,792.5)		380.9		(1,411.6)
Net unrealized gains on derivative instruments during the period		66.2		(14.2)		52.0
Reclassification adjustment for gains included in net income (3)		(5.6)		1.5		(4.1)
Adjustments for assumed changes in amortization patterns		(0.3)		—		(0.3)
Adjustments for assumed changes in policyholder liabilities		1.2		(0.2)		1.0
Net unrealized gains on derivative instruments		61.5		(12.9)		48.6
Foreign currency translation adjustment during the period		(336.6)		10.8		(325.8)
Reclassification adjustment for losses included in net income (4)		31.5		—		31.5
Foreign currency translation adjustment		(305.1)		10.8		(294.3)
Unrecognized postretirement benefit obligation during the period		0.6		(0.1)		0.5
Amortization of amounts included in net periodic benefit cost (5)		14.4		(3.9)		10.5
Net unrecognized postretirement benefit obligation		15.0		(4.0)		11.0
Other comprehensive loss	$	(2,021.1)	$	374.8	$	(1,646.3)

	For the three months ended
	March 31, 2019
	Pre-Tax		Tax		After-Tax
	(in millions)
Net unrealized gains on available-for-sale securities during the period	$	1,817.0	$	(392.5)	$	1,424.5
Reclassification adjustment for losses included in net income (1)		8.7		(1.7)		7.0
Adjustments for assumed changes in amortization patterns		(122.1)		25.7		(96.4)
Adjustments for assumed changes in policyholder liabilities		(300.3)		69.5		(230.8)
Net unrealized gains on available-for-sale securities		1,403.3		(299.0)		1,104.3
Noncredit component of impairment losses on fixed maturities, available-for-sale during the period		(2.8)		0.6		(2.2)
Adjustments for assumed changes in amortization patterns		(0.4)		0.1		(0.3)
Noncredit component of impairment losses on fixed maturities, available-for-sale (2)		(3.2)		0.7		(2.5)
Net unrealized losses on derivative instruments during the period		(8.5)		1.8		(6.7)
Reclassification adjustment for gains included in net income (3)		(2.3)		0.3		(2.0)
Adjustments for assumed changes in amortization patterns		1.9		(0.4)		1.5
Adjustments for assumed changes in policyholder liabilities		3.6		(0.9)		2.7
Net unrealized losses on derivative instruments		(5.3)		0.8		(4.5)
Foreign currency translation adjustment during the period		40.9		(2.6)		38.3
Reclassification adjustment for gains included in net income		(0.4)		—		(0.4)
Foreign currency translation adjustment		40.5		(2.6)		37.9
Amortization of amounts included in net periodic benefit cost (5)		15.7		(4.2)		11.5
Net unrecognized postretirement benefit obligation		15.7		(4.2)		11.5
Other comprehensive income	$	1,451.0	$	(304.3)	$	1,146.7

(1) Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) on the consolidated statements of operations.

(2) Prior to 2020, represents the net impact of (1) unrealized gains resulting from reclassification of previously recognized noncredit impairment losses from OCI to net realized capital gains (losses) for fixed maturities with bifurcated OTTI that had additional credit losses or fixed maturities that previously had bifurcated OTTI that have now been sold or are intended to be sold and (2) unrealized losses resulting from reclassification of noncredit impairment losses for fixed maturities with bifurcated OTTI from net realized capital gains (losses) to OCI.

(3) See Note 4, Derivative Financial Instruments, under the caption “Effect of Fair Value and Cash Flow Hedges on Consolidated Statements of Operations” for further details.

(4) The 2020 pre-tax reclassification adjustment primarily related to the release of the cumulative translation adjustment from the dissolution of a foreign subsidiary.

(5) Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 7, Employee and Agent Benefits, under the caption “Components of Net Periodic Benefit Cost” for further details.

Accumulated Other Comprehensive Income (Loss)

			Noncredit
	Net unrealized		component of		Net unrealized		Foreign		Unrecognized		Accumulated
	gains on		impairment losses		gains		currency		postretirement		other
	available-for-sale		on fixed maturities		on derivative		translation		benefit		comprehensive
	securities (1)		available-for-sale (2)		instruments		adjustment		obligation		income (loss)
	(in millions)
Balances as of January 1, 2019	$	190.0	$	(47.1)	$	64.4	$	(1,259.5)	$	(512.9)	$	(1,565.1)
Other comprehensive income during the period, net of adjustments		1,097.3		(2.5)		(2.5)		37.8		—		1,130.1
Amounts reclassified from AOCI		7.0		—		(2.0)		(0.4)		11.5		16.1
Other comprehensive income		1,104.3		(2.5)		(4.5)		37.4		11.5		1,146.2
Balances as of March 31, 2019	$	1,294.3	$	(49.6)	$	59.9	$	(1,222.1)	$	(501.4)	$	(418.9)
Balances as of January 1, 2020	$	2,806.0	$	(44.1)	$	53.4	$	(1,341.8)	$	(435.6)	$	1,037.9
Other comprehensive loss during the period, net of adjustments		(1,404.4)		—		52.7		(316.9)		0.5		(1,668.1)
Amounts reclassified from AOCI		(6.9)		—		(4.1)		31.5		10.5		31.0
Other comprehensive loss		(1,411.3)		—		48.6		(285.4)		11.0		(1,637.1)
Effects of implementation of accounting change related to credit losses, net		(44.1)		44.1		—		—		—		—
Balances as of March 31, 2020	$	1,350.6	$	—	$	102.0	$	(1,627.2)	$	(424.6)	$	(599.2)

(1) Net unrealized losses on available-for-sale debt securities for which an allowance for credit loss has been recorded were $3.3 million as of March 31, 2020.

(2) Prior to the implementation of authoritative guidance in 2020, the noncredit component of impairment losses on fixed maturities, available-for-sale was included as a separate component of stockholders' equity.

Noncontrolling Interest

Interests held by unaffiliated parties in consolidated entities are reflected in noncontrolling interest, which represents the noncontrolling partners’ share of the underlying net assets of our consolidated subsidiaries. Noncontrolling interest that is not redeemable is reported in the equity section of the consolidated statements of financial position.

The noncontrolling interest holders in certain of our consolidated entities maintain an equity interest that is redeemable at the option of the holder, which may be exercised on varying dates. Since redemption of the noncontrolling interest is outside of our control, this interest is excluded from stockholders’ equity and reported separately as redeemable noncontrolling interest on the consolidated statements of financial position. Our redeemable noncontrolling interest primarily relates to consolidated sponsored investment funds for which interests are redeemed at fair value from the net assets of the funds.

For our redeemable noncontrolling interest related to other consolidated subsidiaries, redemptions are required to be purchased at fair value or a value based on a formula that management intended to reasonably approximate fair value based on a fixed multiple of earnings over a measurement period. The carrying value of the redeemable noncontrolling interest is compared to the redemption value at each reporting period. Any adjustments to the carrying amount of the redeemable noncontrolling interest for changes in redemption value prior to exercise of the redemption option are determined after the attribution of net income or loss of the subsidiary and are recognized in the redemption value as they occur. Adjustments to the carrying value of redeemable noncontrolling interest result in adjustments to additional paid-in capital and/or retained earnings. Adjustments are recorded in retained earnings to the extent the redemption value of the redeemable noncontrolling interest exceeds its fair value and will impact the numerator in our earnings per share calculations. All other adjustments to the redeemable noncontrolling interest are recorded in additional paid-in capital.

Following is a reconciliation of the changes in the redeemable noncontrolling interest (in millions):

	For the three months ended
	March 31,
	2020		2019
	(in millions)
Balance at beginning of period	$	264.9	$	391.2
Net income (loss) attributable to redeemable noncontrolling interest		(23.7)		20.3
Contributions from redeemable noncontrolling interest		34.2		143.7
Distributions to redeemable noncontrolling interest		(29.7)		(20.3)
Change in redemption value of redeemable noncontrolling interest		0.6		2.7
Other comprehensive income (loss) attributable to redeemable noncontrolling interest		(6.6)		0.1
Balance at end of period	$	239.7	$	537.7